Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1595361

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1595361

Pigmentation Disorders Treatment Market by Indication (Hyperpigmentation, Hypopigmentation), Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing), End User - Global Forecast 2025-2030

PUBLISHED:
PAGES: 193 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Pigmentation Disorders Treatment Market was valued at USD 6.78 billion in 2023, expected to reach USD 7.28 billion in 2024, and is projected to grow at a CAGR of 7.42%, to USD 11.21 billion by 2030.

The Pigmentation Disorders Treatment market encompasses therapies and solutions aimed at correcting abnormalities in skin coloration caused by factors such as melanin overproduction, hormonal imbalances, or genetic conditions. This market holds significant necessity due to the growing demand for aesthetically pleasing skin and the increasing prevalence of pigmentation disorders like melasma, vitiligo, and hyperpigmentation. Applications include topical ointments, laser therapies, chemical peels, and pharmaceutical interventions primarily used by dermatologists and cosmetic clinics. The end-use scope extends to both medical facilities and direct consumer skincare brands focused on beauty and wellness.

KEY MARKET STATISTICS
Base Year [2023] USD 6.78 billion
Estimated Year [2024] USD 7.28 billion
Forecast Year [2030] USD 11.21 billion
CAGR (%) 7.42%

Market growth is bolstered by advancements in dermatological technology and increasing consumer awareness about skin health. Rising disposable incomes in emerging economies and a trend towards self-care are leading to greater adoption rates of treatment options. Moreover, the development of more effective, less invasive treatments offers substantial opportunities for market expansion. However, limitations such as the high cost of advanced treatments, a lack of universal insurance coverage, and the potential for side effects pose challenges. Further, the market is fragmented with regional variances in product availability and patient access to treatments.

To capitalize on growth opportunities, businesses should invest in next-generation therapies that minimize side effects and offer faster results, such as gene therapy and bioengineered skin treatments. Enhancing research into personalized and ethnically-tailored treatment regimens can also drive market leadership. The nature of this market is competitive, characterized by continuous innovation, regulatory scrutiny, and a fast pace of technological advancements. Effective market strategies should focus on strategic partnerships, mergers, and acquisitions to bolster research and development capabilities. Innovative marketing targeting younger demographics and leveraging digital health platforms could also enhance consumer engagement and broaden market reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness and concerns about importance of skincare
    • Growing expenditure on cosmetics and skincare products
    • Rising R&D spending and aggressive marketing strategies
  • Market Restraints
    • High cost of treatments and varying output results
  • Market Opportunities
    • Technological advancements like laser treatment and needling process
    • Advancements in various drugs like azelaic acid
  • Market Challenges
    • Increasing skin sensitivity, allergies and reactions to some

Porter's Five Forces: A Strategic Tool for Navigating the Pigmentation Disorders Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pigmentation Disorders Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pigmentation Disorders Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pigmentation Disorders Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pigmentation Disorders Treatment Market

A detailed market share analysis in the Pigmentation Disorders Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pigmentation Disorders Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pigmentation Disorders Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pigmentation Disorders Treatment Market

A strategic analysis of the Pigmentation Disorders Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pigmentation Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include Affiliated Dermatology, Allergan, Inc., Derma Med Spa, EpiPharm AG, GK Dermatology, PC, Kaya Limited, La Roche-Posay by L'Oreal Singapore Pte. Ltd., Obagi Cosmeceuticals LLC, Skin Deep Laser Services, VIVIER PHARMA USA, and Water's Edge Dermatology.

Market Segmentation & Coverage

This research report categorizes the Pigmentation Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Hyperpigmentation and Hypopigmentation.
  • Based on Treatment & Therapies, market is studied across Chemical Peels, Dermabrasion, Laser Resurfacing, and Melasma.
  • Based on End User, market is studied across Dermatology Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-030EE4851634

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness and concerns about importance of skincare
      • 5.1.1.2. Growing expenditure on cosmetics and skincare products
      • 5.1.1.3. Rising R&D spending and aggressive marketing strategies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatments and varying output results
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements like laser treatment and needling process
      • 5.1.3.2. Advancements in various drugs like azelaic acid
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing skin sensitivity, allergies and reactions to some
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pigmentation Disorders Treatment Market, by Indication

  • 6.1. Introduction
  • 6.2. Hyperpigmentation
  • 6.3. Hypopigmentation

7. Pigmentation Disorders Treatment Market, by Treatment & Therapies

  • 7.1. Introduction
  • 7.2. Chemical Peels
  • 7.3. Dermabrasion
  • 7.4. Laser Resurfacing
  • 7.5. Melasma

8. Pigmentation Disorders Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Dermatology Clinics
  • 8.3. Hospitals

9. Americas Pigmentation Disorders Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pigmentation Disorders Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pigmentation Disorders Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Affiliated Dermatology
  • 2. Allergan, Inc.
  • 3. Derma Med Spa
  • 4. EpiPharm AG
  • 5. GK Dermatology, PC
  • 6. Kaya Limited
  • 7. La Roche-Posay by L'Oreal Singapore Pte. Ltd.
  • 8. Obagi Cosmeceuticals LLC
  • 9. Skin Deep Laser Services
  • 10. VIVIER PHARMA USA
  • 11. Water's Edge Dermatology
Product Code: MRR-030EE4851634

LIST OF FIGURES

  • FIGURE 1. PIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPERPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPOPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMABRASION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER RESURFACING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!